Molecular diagnostic solutions for respiratory infection testing

Prompt and early diagnosis of respiratory pathogens that cause severe illness is critical to help inform patient management, treatment decisions, and preventing the spread of disease.  Confidence in testing results allows clinicians and patients to make informed decisions—including seeking medical care and/or avoiding contact with other people. While many testing options are available for respiratory testing, molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.

Webinar: Viruses Circulating in the 2023–2024 Flu Season: What Have We Seen?

TaqPath COVID-19 Combo Kit

The Applied Biosystems TaqPath COVID-19 Combo Kit is a real-time PCR multiplex diagnostic solution developed by Thermo Fisher Scientific. It is specifically designed for the in vitro diagnosis of COVID-19, caused by SARS-CoV-2 infection. The kit is authorized for use with six types of patient samples and includes all necessary assays and controls for the real-time PCR detection of RNA from SARS-CoV-2. Its multi-target design helps compensate for emerging SARS-CoV-2 mutations and variants, including the potential early identification of the Omicron variant. The kit also includes Applied Biosystems COVID-19 Interpretive Software, which automatically converts genetic analysis data into a report, reducing the risk of user interpretation error.

TaqPath COVID-19, Flu A, Flu B Combo Kit

Boost your lab's efficiency with the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit by Thermo Fisher Scientific. This high-precision multiplex real-time PCR test enables simultaneous detection and differentiation of SARS-CoV-2, influenza A, and influenza B. Designed to accommodate emerging SARS-CoV-2 variants, this kit expands your respiratory sample testing capabilities while maintaining low operational costs. Authorized for use with multiple sample types, it is designed to deliver a turnaround time of approximately 3 hours. The kit includes the Pathogen Interpretive Software, aimed at transforming complex genetic data into easy-to-read reports and minimizing interpretation errors. Enhance your diagnostic accuracy and efficiency with this comprehensive solution.

TaqPath COVID-19 RNase P Combo Kit 2.0

The TaqPath COVID-19 RNase P Combo Kit 2.0 is a PCR-based test designed for accurate and efficient detection of SARS-CoV-2. The kit's innovative multi-target assay design targets 8 different regions across 3 genes, providing a robust response to emerging COVID-19 mutations. It includes RNase P control for human sample confirmation, helping ensure sample integrity and quality. With a limit of detection of 75 GCE/mL, it helps provide sensitive detection for both symptomatic and asymptomatic individuals. The kit is scalable, compatible with widely used qPCR systems, and can be conveniently stored at -20°C.

TaqPath COVID-19 Fast PCR Combo Kit 2.0

The TaqPath COVID-19 Fast PCR Combo Kit 2.0 offers a reliable, fast, and affordable solution for high-frequency COVID-19 testing. It uses a simplified, direct-to-PCR workflow from raw saliva samples, bypassing RNA extraction, and is designed to deliver results in just about 2 hours. The product utilizes multi-target assay design across 3 genomic regions to compensate for SARS-CoV-2 mutations, allowing increased confidence in results.